---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-037851"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:28:48.631773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Masimo board authorizes evaluation of consumer business separation; retains healthcare

## Summary
- Board authorized management to evaluate separation of consumer business (audio + health products: Stork, Freedom).
- Masimo will retain professional healthcare and telehealth products; expects improved profitability.
- Joe Kiani to remain Chairman and CEO of Masimo and become Chairman of the new company.
- Separation timing subject to due diligence, definitive agreements, SEC clearance, and regulatory approvals.
- Masimo reaffirms Q1 and fiscal 2024 financial guidance.

## SEC filing metadata
- accession: 0001104659-24-037851
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000110465924037851/0001104659-24-037851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000110465924037851/tm249575d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-037851
- JSON: https://secwatch.observer/filing/0001104659-24-037851.json
- Plain text: https://secwatch.observer/filing/0001104659-24-037851.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.